Biomedical Chemistry: Research and Methods 2021, 4(3), e00091

Expression and Isolation of N-Terminal Truncated Human Recombinant Renalase in Prokaryotic Cells

V.I. Fedchenko *, A.A. Kaloshin, S.A. Kaloshina, A.E. Medvedev

Institute of Biomedical Chemistry, 10 Pogodinskaya str., Moscow, 119121 Russia; *e-mail:

Keywords: renalase; protein expression; inclusion bodies; protein solubilization; isolation


The whole version of this paper is available in Russian.

Renalase (RNLS) is a flavoproteinin which its N-terminal peptide (residues 1-17) has several important functions. In cells, it participates in the formation of the so-called Rossmanfold (residues 2-35), needed for «accommodation» of the FAD cofactor and for performing the catalytic functions of RNLS as a FAD-dependent oxidoreductase (EC RNLS secretion into the extracellular space is accompanied by cleavage of this peptide. The resultant truncated extracellular RNLS cannot bind FAD and therefore performs various noncatalytic functions. In this work, we have performed expression the genetic construct encoding RNLS lacking its N-terminal signal peptide (tRNLS) in E. coli Rosetta (DE3) cells. The recombinant protein was accumulated in inclusion bodies in an insoluble form, which could be solubilized in the presence of a high concentration of urea or guanidine chloride. In contrast to full-length RNLS, which was effectively solubilized in the presence of 8 M urea, tRNLS was preferentially solubilized in the presence of 6 M guanidine chloride.

Figure 1. Analysis of the protein products obtained after expression of the vector pET-hRen(-sp) in Е. coli Rosetta (DE3) cells. Tracks: 1 – molecular weight protein markers (arrows indicate protein markers of 70 kDa, 55 kDa, 45 kDa, 35 kDa, and 25 kDa. 2 – proteins produced by the cells without IPTG stimulation; 3 – proteins produced by IPTG stimulated cells; 4 – inclusion bodies containing recombinant tRNLS; 4 – chromatographically purified tRNLS.
Figure 2. Analysis of recombinant tRNLS solubilization from inclusion bodies in the buffer containing 8 M urea. Here and in the subsequent figure a – supernatant after inclusion bodies solubilization and centrifugation; b – sediment after inclusion bodies solubilization and centrifugation. Tracks: 1 – incubation for 15 min; 2 – incubation for 30 min; 3 – incubation for 1 h; 4 – incubation for 12 h.
Figure 3. Analysis of recombinant tRNLS solubilization from inclusion bodies in the buffer containing 6 М GdnHCl.


This work was supported by a grant from the Russian Foundation for Basic Research (project number 20–015–00104).


  1. Xu J., Li G., Wang P., Velazquez H., Yao X., Li Y, Wu Y., Peixoto A., Crowley S., Desir G.V. (2005) Renalase is a novel, soluble monoamine oxidase that regulates cardiac function and blood pressure. J. Clin. Invest.,115, 1275–1280. DOI
  2. Milani M., Ciriello F., Baroni S., Pandini V., Canevari G.,Bolognesi M., Aliverti A. (2011) FAD-binding site and NADP reactivity in human renalase: a new enzyme involved in blood pressure regulation. J. Mol. Biol., 411(2), 463-473. DOI
  3. Fedchenko V.I., Buneeva O.A., Kopylov A.T., Veselovsky A.V., Zgoda V.G., Medvedev A.E. (2015) Human urinary renalase lacks the N-terminal signal peptide crucial for accommodation of its FAD cofactor. International Journal of Biological Macromolecules, 78, 347–353. DOI
  4. Moran G.R., Hoag M.R. (2017) The enzyme: Renalase. Arch. Biochem. Biophys.,632, 66-76. DOI
  5. Fedchenko V., Kopylov A., Kozlova N., Buneeva O., Kaloshin A., ZgodaV., Medvedev A. (2016) Renalase secreted by human kidney НЕК293Т cells lacks its N-terminal peptide: implications for putative mechanisms of renalase action. Kidney Blood Press. Res., 41, 593-603. DOI
  6. Medvedev A.E., Veselovsky A.V., Fedchenko V.I. (2010) Renalase, a new secretory enzyme responsible for selective degradation of catecholamines: achievements and unsolved problems. Biochemistry (Moscow), 75(8), 951-958. DOI
  7. Severina I.S., Fedchenko V.I., Veselovsky A.V., Medvedev A.E.(2015) The history of renalase from amine oxidase to a α-NAD(P)H-oxidase/anomerase. Biomed Khim. 2015,61(6), 667-679. DOI
  8. Wang Y., Safirstein R., Velazquez H., Guo X.J., Hollander L., Chang J., Chen T.M., Mu J.J., Desir G.V. (2017) Extracellular renalase protects cells and organs by outside-in signalling. J. Cell Mol. Med., 21(7), 1260-1265. DOI
  9. Pointer T.C., Gorelick F.S., Desir G.V.(2021) Renalase: a multi-functional signaling molecule with roles in gastrointestinal disease. Cells, 10(8), 2006. DOI
  10. Wang, R.P. peptide Wang L., Velazquez H., Chang J., Safirstein R., Desir G.V. (2015) Identification of a receptor for extracellular renalase. PLoS One, 10, e0122932. DOI
  11. Fedchenko V.I., Kaloshin A.A., Kozlova N.I., Kopylov, A.T., Medvedev A.E.(2020) Construction of a chimeric human gene encoding renalase with a modified N-terminus. Biomedical Chemistry: Research and Methods, 3(3), e00137. DOI
  12. Fedchenko V. I., Kaloshin A.A., Mezhevikina L.M., Buneeva O.A., Medvedev A.E. (2013) Construction of the coding sequence of the transcription variant 2 of the human renalase gene and its expression in the prokaryotic system. Int. J. Mol. Sci. 14, 12764-12779. DOI
  13. Laemmli, U.K. (1970) Cleavage of structural proteins during the assemblyof the head of bacteriophage T4. Nature; 227, 680-685. DOI
  14. Kushner, S. R. (1978). An improved method for transformation of Escherichia coli with ColE1-derived plasmids. In: Genetic engineering (Boyer H.B. and Nicosia S., eds.), p. 17, Elsevier/North-Holland, Amsterdam.
  15. Cohen, S.N., Chang, A.C.Y., Hsu, L. (1972). Nonchromosomal antibiotic resistance in bacteria: genetic transformation of Esherichia coli by R-factor DNA. Proc. Natl. Acad. Sci. USA, 69, 2110-2114.
  16. Fedchenko V.I., Kaloshin A.A. (2019) A simplified method for obtainingcDNA of low-copy and silent eukaryotic genes using human renalase as anexample. Biomedical Chemistry: Research and Methods. 2(2), e00101. DOI
  17. Khomenko V.A., Sidorin E.V., Bakholdina S.I., Naberezhnykh G.A., Kim N.Y., Stenkova A.M., Chernysheva N.Y., Isaeva M.P., Solov'eva T.F. (2019) Inclusion Bodies of Recombinant OmpF Porin from Yersinia pseudotuberculosis: Properties and Structural Characterization. Biochemistry (Mosc), 84(6), 672-685. DOI
  18. Park A.R., Jang S.W., Kim J.S., Park Y.G., Koo B.S., Lee H.C. (2018) Efficient recovery of recombinant CRM197 expressed as inclusion bodies in E. coli. PLoS One. 3(7), e0201060. DOI
  19. Pandini V., Ciriello F., Tedeschi G., Rossoni G.; Zanetti G., Aliverti A. (2010) Synthesis of human renalase1 in Escherichia coli and its purification as a FAD-containing holoprotein. Protein Expr. Purif., 72, 244–253.
  20. Eiberle, M.K.; Jungbauer, A. (2010) Technical refolding of proteins: Do we have freedom to operate? Biotechnol. J. 5(6), 547-559. DOI
  21. Gautam S., Dubey P., Rather G.M., Gupta M.N. (2012) Non-chromatographic strategies for protein refolding. Recent Pat Biotechnol., 6(1), 57-68. DOI
  22. Machold C., Schlegl R., Buchinger W., Jungbauer A. (2005) Matrix assisted refolding of proteins by ion exchange chromatography. J. Biotechnol. 117, 83-97. DOI
  23. Clark E.D.B.(2001) Protein refolding for industrial processes. Curr. Opin. Biotechnol., 12, 207-202
  24. Marston F.A.O. (1986) The purification of eukaryotic polypeptides synthesized in Escherichia coli. Biochem. J., 240, 1-12.